Literature DB >> 26437875

Slow intestinal transit contributes to elevate urinary p-cresol level in Italian autistic children.

Stefano Gabriele1,2, Roberto Sacco1,2, Laura Altieri1,2, Cristina Neri3,4, Andrea Urbani3,4, Carmela Bravaccio5, Maria Pia Riccio6, Maria Rosaria Iovene7, Francesca Bombace7, Laura De Magistris8, Antonio M Persico1,2,9.   

Abstract

The uremic toxin p-cresol (4-methylphenol) is either of environmental origin or can be synthetized from tyrosine by cresol-producing bacteria present in the gut lumen. Elevated p-cresol amounts have been previously found in the urines of Italian and French autism spectrum disorder (ASD) children up until 8 years of age, and may be associated with autism severity or with the intensity of abnormal behaviors. This study aims to investigate the mechanism producing elevated urinary p-cresol in ASD. Urinary p-cresol levels were thus measured by High Performance Liquid Chromatography in a sample of 53 Italian ASD children assessed for (a) presence of Clostridium spp. strains in the gut by means of an in vitro fecal stool test and of Clostridium difficile-derived toxin A/B in the feces, (b) intestinal permeability using the lactulose/mannitol (LA/MA) test, (c) frequent use of antibiotics due to recurrent infections during the first 2 years of postnatal life, and (d) stool habits with the Bristol Stool Form Scale. Chronic constipation was the only variable significantly associated with total urinary p-cresol concentration (P < 0.05). No association was found with presence of Clostridium spp. in the gut flora (P = 0.92), augmented intestinal permeability (P = 0.18), or frequent use of antibiotics in early infancy (P = 0.47). No ASD child was found to carry C. difficile in the gut or to release toxin A/B in the feces. In conclusion, urinary p-cresol levels are elevated in young ASD children with increased intestinal transit time and chronic constipation. Autism Res 2016, 9: 752-759.
© 2015 International Society for Autism Research, Wiley Periodicals, Inc. © 2015 International Society for Autism Research, Wiley Periodicals, Inc.

Entities:  

Keywords:  autism; autism spectrum disorder; biomarker; constipation; gut; intestinal transit; neurotoxicity; organic contaminants

Mesh:

Substances:

Year:  2015        PMID: 26437875     DOI: 10.1002/aur.1571

Source DB:  PubMed          Journal:  Autism Res        ISSN: 1939-3806            Impact factor:   5.216


  21 in total

Review 1.  Defining Dysbiosis in Disorders of Movement and Motivation.

Authors:  Christopher T Fields; Timothy R Sampson; Annadora J Bruce-Keller; Drew D Kiraly; Elaine Y Hsiao; Geert J de Vries
Journal:  J Neurosci       Date:  2018-10-31       Impact factor: 6.167

Review 2.  The phenolic interactome and gut microbiota: opportunities and challenges in developing applications for schizophrenia and autism.

Authors:  George E Jaskiw; Mark E Obrenovich; Curtis J Donskey
Journal:  Psychopharmacology (Berl)       Date:  2019-06-13       Impact factor: 4.530

Review 3.  The gut-kidney axis.

Authors:  Pieter Evenepoel; Ruben Poesen; Björn Meijers
Journal:  Pediatr Nephrol       Date:  2016-11-15       Impact factor: 3.714

4.  Accumulation of uraemic toxins is reflected only partially by estimated GFR in paediatric patients with chronic kidney disease.

Authors:  Evelien Snauwaert; Wim Van Biesen; Ann Raes; Els Holvoet; Griet Glorieux; Koen Van Hoeck; Maria Van Dyck; Nathalie Godefroid; Raymond Vanholder; Sanne Roels; Johan Vande Walle; Sunny Eloot
Journal:  Pediatr Nephrol       Date:  2017-09-22       Impact factor: 3.714

Review 5.  Effects of the L-tyrosine-derived bacterial metabolite p-cresol on colonic and peripheral cells.

Authors:  F Blachier; M Andriamihaja
Journal:  Amino Acids       Date:  2021-09-01       Impact factor: 3.520

6.  Intestinal Dysbiosis and Yeast Isolation in Stool of Subjects with Autism Spectrum Disorders.

Authors:  Maria Rosaria Iovene; Francesca Bombace; Roberta Maresca; Anna Sapone; Patrizia Iardino; Annarita Picardi; Rosa Marotta; Chiara Schiraldi; Dario Siniscalco; Nicola Serra; Laura de Magistris; Carmela Bravaccio
Journal:  Mycopathologia       Date:  2016-09-21       Impact factor: 2.574

Review 7.  The Gut Microbiota and Dysbiosis in Autism Spectrum Disorders.

Authors:  Heather K Hughes; Destanie Rose; Paul Ashwood
Journal:  Curr Neurol Neurosci Rep       Date:  2018-09-24       Impact factor: 5.081

8.  Gut mobilization improves behavioral symptoms and modulates urinary p-cresol in chronically constipated autistic children: A prospective study.

Authors:  Laura Turriziani; Arianna Ricciardello; Francesca Cucinotta; Fabiana Bellomo; Giada Turturo; Maria Boncoddo; Silvestro Mirabelli; Maria Luisa Scattoni; Maddalena Rossi; Antonio M Persico
Journal:  Autism Res       Date:  2021-11-23       Impact factor: 4.633

Review 9.  The Significance of the Enteric Microbiome on the Development of Childhood Disease: A Review of Prebiotic and Probiotic Therapies in Disorders of Childhood.

Authors:  John Slattery; Derrick F MacFabe; Richard E Frye
Journal:  Clin Med Insights Pediatr       Date:  2016-10-09

10.  Urinary 3-(3-Hydroxyphenyl)-3-hydroxypropionic Acid, 3-Hydroxyphenylacetic Acid, and 3-Hydroxyhippuric Acid Are Elevated in Children with Autism Spectrum Disorders.

Authors:  Xiyue Xiong; Dan Liu; Yichao Wang; Ting Zeng; Ying Peng
Journal:  Biomed Res Int       Date:  2016-03-30       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.